| Authors: |
Bahrami E; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Geiger T; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Steixner-Kumar AA; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Santacruz D; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Viollet C; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Dick A; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Roth Y; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Schlingeloff P; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany., Schmidberger J; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany., Haenle M; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany., Kratzer W; Department of Internal Medicine I, University Hospital Ulm, Ulm, Germany., Kitt K; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Neubauer H; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Simon E; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Krenkel O; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Werner M; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany. Electronic address: markus.werner@boehringer-ingelheim.com. |